|

anti-CD19/BCMA CAR NK cells (KN5601) Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • The Children's Hospital of Zhejiang University School of Medicine1

Indications

  • IgAN - IgA Nephropathy1
  • Multi-Drug Resistant Nephrotic Syndrome1
  • Systemic Lupus Erthematosus1
  • Lupus1
  • Autoimmune Diseases1

Other1 trial

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.